Literature DB >> 2996404

Mechanisms of T-cell functional deficiency in the acquired immunodeficiency syndrome.

G V Quinnan, J P Siegel, J S Epstein, J F Manischewitz, S Barnes, M A Wells.   

Abstract

Cell-mediated immune responses to cytomegalovirus infections were studied to define mechanisms for deficient effector T-cell responses in patients with the acquired immunodeficiency syndrome (AIDS). Progressive cytomegalovirus infection is common in such patients and is accompanied by a failure to develop HLA-restricted cytotoxic T-cell responses. The mechanism for the cytotoxic T-cell deficiency is presumably the basis for susceptibility to opportunistic infections. Precursors to these effector cells circulate in the peripheral blood of patients, but maturation of these cells into cytotoxic T cells is arrested during an interleukin-2-dependent phase. Production of interleukin-2 by lymphocytes from patients with AIDS is deficient because sera from these patients contain an inhibitor of interleukin-2 production. Excess suppressor cell activity does not appear to account for this deficient production. Studies of the source of the serum inhibitor should provide insights into the pathogenesis of AIDS and possible leads for effective treatment.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2996404     DOI: 10.7326/0003-4819-103-5-710

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  7 in total

1.  Immune response to cytomegalovirus in patients with acquired-immunodeficiency syndrome related complex (ARC) and AIDS.

Authors:  M C Sirianni; A Volpi; S Soddu; R Mancino; F Aiuti; G Rocchi
Journal:  Eur J Epidemiol       Date:  1987-12       Impact factor: 8.082

2.  Impairment in T-lymphocyte responses during early infection with the human immunodeficiency virus.

Authors:  J Bentin; C D Tsoukas; J A McCutchan; S A Spector; D D Richman; J H Vaughan
Journal:  J Clin Immunol       Date:  1989-03       Impact factor: 8.317

3.  Immunologic abnormalities related to antigenaemia during HIV-1 infection.

Authors:  P De Paoli; S Battistin; M Crovatto; M L Modolo; A Carbone; U Tirelli; G Santini
Journal:  Clin Exp Immunol       Date:  1988-12       Impact factor: 4.330

4.  Lymphocyte subpopulation profiles and mitogen kinetics in immunological deficiency testing.

Authors:  R M Radvany; M S Schubert; M Kiamar; V Jarzabek; K Koehler-Carone; D Kuban; F Hecht
Journal:  J Clin Immunol       Date:  1987-07       Impact factor: 8.317

Review 5.  Autoimmunity and dysmetabolism of human acquired immunodeficiency syndrome.

Authors:  Yan-Mei Huang; Xue-Zhi Hong; Jia-Hua Xu; Jiang-Xi Luo; Han-You Mo; Hai-Lu Zhao
Journal:  Immunol Res       Date:  2016-06       Impact factor: 2.829

6.  Abnormalities of blood selenium and glutathione peroxidase activity in patients with acquired immunodeficiency syndrome and aids-related complex.

Authors:  B M Dworkin; W S Rosenthal; G P Wormser; L Weiss; M Nunez; C Joline; A Herp
Journal:  Biol Trace Elem Res       Date:  1988 Jan-Apr       Impact factor: 3.738

7.  Prolonged immunostimulatory effect of low-dose polyethylene glycol interleukin 2 in patients with human immunodeficiency virus type 1 infection.

Authors:  H Teppler; G Kaplan; K A Smith; A L Montana; P Meyn; Z A Cohn
Journal:  J Exp Med       Date:  1993-02-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.